Distribution Agreements in the Pharmaceuticals Industry
121 Contracts & Agreements
- ACELRX PHARMACEUTICALS INC (1 contract)
- Aclaris Therapeutics, Inc. (1)
- Adamis Pharmaceuticals Corp (3)
- ADERIS PHARMACEUTICALS INC (2)
- Akers Biosciences, Inc. (2)
- Akorn (3)
- ALDER BIOPHARMACEUTICALS INC (1)
- Amphastar Pharma (2)
- Anacor Pharmaceuticals, Inc. (2)
- AYTU BIOSCIENCE, INC (1)
- BRADLEY PHARMACEUTICALS INC (1)
- Canbiola, Inc. (1)
- CANNAPOWDER, INC. (1)
- Corcept Therapeutics Incorporated (7)
- COSMO VENTURES INC (1)
- CUMBERLAND PHARMACEUTICALS INC (4)
- Cure Pharmaceutical Holding Corp. (1)
- GridIron BioNutrients, Inc. (1)
- Horizon Pharma plc (7)
- Jaguar Health, Inc. (1)
- Jazz Pharmaceuticals plc (7)
- KING PHARMACEUTICALS INC (1)
- KOS PHARMACEUTICALS INC (1)
- Lannett Company, Inc. (2)
- Level Brands, Inc. (1)
- Merck (1)
- MICROCHANNEL TECHNOLOGIES CORP (1)
- MJ Holdings, Inc. (1)
- Neuralstem, Inc. (1)
- NovaBay Pharmaceuticals, Inc. (4)
- NPS PHARMACEUTICALS INC (1)
- OSCIENT PHARMACEUTICALS CORP (1)
- Pacira Pharmaceuticals, Inc. (4)
- PLAYERS NETWORK (2)
- Prestige Brands Holdings Inc (1)
- Profile Solutions, Inc. (4)
- QUARK PHARMACEUTICALS INC (1)
- RADIENT PHARMACEUTICALS Corp (2)
- Revance Therapeutics, Inc. (8)
- SAMARITAN PHARMACEUTICALS INC (1)
- SCICLONE PHARMACEUTICALS INC (1)
- Sonoma Pharmaceuticals, Inc. (9)
- TAURIGA SCIENCES, INC. (5)
- The Medicines Company (3)
- TITAN PHARMACEUTICALS INC (1)
- Tribute Pharmaceuticals Canada Inc. (3)
- Valera Pharmaceuticals Inc (1)
- VIA Pharmaceuticals, Inc. (2)
- XANODYNE PHARMACEUTICALS INC (2)
- ZOGENIX, INC. (5)
- Zomedica Pharmaceuticals Corp. (1)
- Fifth Amendment to Exclusive Distribution Agreement dated July 29, 2024 by and between Revance Therapeutics, Inc. and Teoxane SA (Revance Therapeutics, Inc., Filed With SEC on November 7, 2024)
- Fourth Amendment to Exclusive Distribution Agreement dated June 13, 2024 by and between Revance Therapeutics, Inc. and Teoxane SA (Revance Therapeutics, Inc., Filed With SEC on November 7, 2024)
- Distribution Agreement by and between Armstrong Pharmaceuticals, Inc. and Hong Kong Genreach Limited, dated August 28, 2024 (Amphastar Pharma, Filed With SEC on November 7, 2024)
- Exclusive Distribution Agreement, dated October 24, 2024, by and among Teoxane SA, Revance Therapeutics, Inc. and Revance Australia Pty. Ltd (Revance Therapeutics, Inc., Filed With SEC on October 28, 2024)
- Sixth Amendment to the Exclusive Distribution Agreement, dated October 24, 2024, by and among Teoxane SA and Revance Therapeutics, Inc (Revance Therapeutics, Inc., Filed With SEC on October 28, 2024)
- Amendment No. 1 to Distribution Agreement, dated October 17, 2024, by and between Sonoma Pharmaceuticals, Inc. and Medline Industries, LP (Sonoma Pharmaceuticals, Inc., Filed With SEC on October 22, 2024)
- Distribution Agreement, dated August 19, 2024, by and between Sonoma Pharmaceuticals, Inc. and Medline Industries, LP (Sonoma Pharmaceuticals, Inc., Filed With SEC on August 21, 2024)
- Distribution Services Agreement, dated April 1, 2022, by and between The Sera Labs, Inc. and Advanced Legacy Technologies LLC (Cure Pharmaceutical Holding Corp., Filed With SEC on May 17, 2024)
- Third Amendment to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, effective as of April 1, 2024 (Corcept Therapeutics Incorporated, Filed With SEC on May 1, 2024)
- Third Amendment to Exclusive Distribution Agreement dated December 22, 2022, by and between Revance Therapeutics, Inc. and Teoxane SA (Revance Therapeutics, Inc., Filed With SEC on February 28, 2023)
- Structured Monitoring Products, Inc. Distribution Agreement dated January 13, 2023 by and between Zomedica Inc. and Structured Monitoring Products, Inc (Zomedica Pharmaceuticals Corp., Filed With SEC on January 20, 2023)
- Amendment No. 6, dated as of August 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Jazz Pharmaceuticals plc, Filed With SEC on November 9, 2022)
- Second Amendment to Exclusive Distribution Agreement, dated November 18, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA (Revance Therapeutics, Inc., Filed With SEC on November 8, 2022)
- Amendment No. 2 to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, made and entered into as of September 16, 2022 (Corcept Therapeutics Incorporated, Filed With SEC on November 3, 2022)
- Amendment to Distribution Services Agreement by and between Optime Care, Inc. and Corcept Therapeutics Incorporated, made and entered into as of August 1, 2022 (Corcept Therapeutics Incorporated, Filed With SEC on November 3, 2022)
- Task Order Number One to Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Corcept Therapeutics Incorporated, Filed With SEC on November 3, 2022)
- Distribution Services Agreement, dated August 4, 2017, between Corcept Therapeutics Incorporated and Optime Care, Inc (Corcept Therapeutics Incorporated, Filed With SEC on November 3, 2022)
- Amendment No. 5, dated as of June 24, 2022, to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Jazz Pharmaceuticals plc, Filed With SEC on August 3, 2022)
- Amendment No. 4, dated as of April 18, 2022 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts... (Jazz Pharmaceuticals plc, Filed With SEC on May 4, 2022)
- PrimeX Distribution Agreement (Canbiola, Inc., Filed With SEC on April 15, 2022)
- Distribution Agreement (MICROCHANNEL TECHNOLOGIES CORP, Filed With SEC on November 12, 2021)
- Amendment No. 1 to Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on August 26, 2021)
- Distribution Agreement Between Respirent Pharmaceuticals Co. Ltd. and Lannett Company, Inc (Lannett Company, Inc., Filed With SEC on August 26, 2021)
- Amendment No. 2, dated as of July 19, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Jazz Pharmaceuticals plc, Filed With SEC on August 3, 2021)
- Amendment No. 1, dated as of July 4, 2021 to Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty... (Jazz Pharmaceuticals plc, Filed With SEC on August 3, 2021)
- Co-Development and Distribution Agreement, by and between Leading BioSciences, Inc. and Newsoara Biopharma Co., Ltd. (as successor-in-interest to Biolead Medical Technology... (Neuralstem, Inc., Filed With SEC on December 23, 2020)
- Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Gabriel Science, LLC, effective December 14, 2020 (Sonoma Pharmaceuticals, Inc., Filed With SEC on December 17, 2020)
- Exclusive Licensing and Distribution Agreement between Sonoma Pharmaceuticals, Inc. and Crown Laboratories, Inc., effective December 4, 2020 (Sonoma Pharmaceuticals, Inc., Filed With SEC on December 10, 2020)
- First Amendment to Exclusive Distribution Agreement (Revance Therapeutics, Inc., Filed With SEC on November 9, 2020)
- Distribution Agreement between the Registrant and Biomet 3i LLC d/b/a Zimmer Biomet Dental, dated July 17, 2020 (ACELRX PHARMACEUTICALS INC, Filed With SEC on November 5, 2020)
- Distribution and Commercialization Agreement between the Company and USWM, LLC (Adamis Pharmaceuticals Corp, Filed With SEC on August 17, 2020)
- First Amendment to Intermediary Distribution Agreement between the Company and Chongqing Pioneer Pharma Holdings Limited, dated June 29, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on August 6, 2020)
- Pharmacy Master Services Agreement, dated as of July 1, 2020, by and between Jazz Pharmaceuticals, Inc. and Express Scripts Specialty Distribution Services, Inc (Jazz Pharmaceuticals plc, Filed With SEC on August 4, 2020)
- Distribution Agreement between the Company and Sai Krishna LLC, dated April 30, 2019 filed on Current Report 8-K on May 3, 2019 (TAURIGA SCIENCES, INC., Filed With SEC on June 29, 2020)
- Intermediary Distribution Agreement, dated April 16, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on April 20, 2020)
- International Distribution Agreement, dated April 16, 2020 (NovaBay Pharmaceuticals, Inc., Filed With SEC on April 20, 2020)
- Form of Distribution Agreement dated February 26, 2020 by and among cbdMD, Inc., CBD Holdings, LLC and the members of CBD Holdings, LLC (Level Brands, Inc., Filed With SEC on February 28, 2020)
- Exclusive Distribution Agreement, dated January 10, 2020, by and between Revance Therapeutics, Inc. and Teoxane SA (Revance Therapeutics, Inc., Filed With SEC on February 26, 2020)
- Distribution Agreement (COSMO VENTURES INC, Filed With SEC on October 11, 2019)
- Distribution Agreement between the Company and Windmill Health Products, LLC, dated June 28, 2019 (TAURIGA SCIENCES, INC., Filed With SEC on July 5, 2019)
